• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Abbott forecasts 2024 earnings largely below estimates, shares down

cafead

Administrator
Staff member
  • cafead   Jan 24, 2024 at 09:42: AM
via Abbott Laboratories on Wednesday forecast 2024 profit largely below Wall Street estimates despite meeting quarterly earnings expectations, sending the medical device maker's shares down 2.5% in premarket trading.

article source
 

<